Phase I/Ib Clinical Trial of ABTL0812 in Advanced Cancer Patients
Clinical trial NCT02201823 · COMPLETED
Trial details
- NCT number
- NCT02201823
- Sponsor
- Ability Pharmaceuticals SL
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2015-03-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.